Setmelanotide
DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway
Rhythm · Phase 2 · Completed · Enrollment 164
Y axis: Change in body weight from baseline, %
X axis: Weeks since randomization
Cited trial source. Only weeks the source states.
- Stage 1: Setmelanotide (Open-Label): week 16 -3.94%
One reported week is a point at that week. It is not a line from 0%. A solid line connects two or more reported weeks.